SCHEMBL31435581

SCHEMBL31435581

COC(=O)c1c(-c2cnn(C)c2)sc2c1CCCC2=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 2/20 0.42
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 4/20 0.40
HPGD P15428 3/20 0.40
GAA P10253 1/20 0.40
HIF1A Q16665 1/20 0.40
USP2 O75604 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 3/20 0.38
TLR2 O60603 3/20 0.38
MAPT P10636 5/20 0.38
HTT P42858 1/20 0.38
TP53 P04637 1/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31435597 0.87 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2LMNAKMT2AKDM4E
SCHEMBL9722751 0.72 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2LMNAKMT2AKDM4E
SCHEMBL31435555 0.72 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2LMNAKDM4EHPGD
SCHEMBL31435578 0.69 DRD4 (0.44) ALDH1A1KDM4EPOLB
SCHEMBL31435611 0.69 HDAC6 (0.39) ALDH1A1LMNA
SCHEMBL31435609 0.66 CYP11B2 (0.37) ALDH1A1LMNA
SCHEMBL3318720 0.66 PTGS2 (0.70) ALDH1A1SMN1; SMN2KDM4EHPGDUSP2
SCHEMBL25299953 0.65 ERN1 (0.45) ALDH1A1SMN1; SMN2LMNAHPGDMAPT
SCHEMBL21597638 0.65 KDM4E (0.67) ALDH1A1SMN1; SMN2LMNARAB9AKDM4E
SCHEMBL22102931 0.64 ACACB (0.39) ALDH1A1LMNARAB9AKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119661516-A Bicyclic heterocyclic compounds, preparation method and medical application thereof 华润医药研究院(深圳)有限公司 2025-03-21 CN disclosed